MONAGHAN MEDICAL WINS 2024 AARC ZENITH AWARD
Monaghan Medical Corporation proudly received the 2024 Zenith Award from the American Association for Respiratory Care (AARC), recognizing our excellence in respiratory care. Honored for product quality, customer support, and industry contributions, this prestigious award highlights our ongoing commitment to improving patient outcomes.
Read the post:MONAGHAN MEDICAL WINS 2024 AARC ZENITH AWARD
MONAGHAN MEDICAL CORPORATION ATTAINS ISO 14001 CERTIFICATION FOR ENVIRONMENTAL MANAGEMENT EXCELLENCE
Monaghan Medical Corporation (MMC) is proud to have achieved ISO 14001 certification, underscoring the company’s dedication to continually improving environmental management practices.
Read the post:MONAGHAN MEDICAL CORPORATION ATTAINS ISO 14001 CERTIFICATION FOR ENVIRONMENTAL MANAGEMENT EXCELLENCE
With Monaghan Medical, Safe Nebulizer Therapy is Possible
Monaghan Medical Is Focused on Protecting Caregivers while Providing Quality Therapy for Patients PLATTSBURGH, NY (February 23, 2021) – Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy. Nebulizer therapy is a common treatment for many pulmonary respiratory conditions. However, passive inhalation of exhaled emissions including […]
Read the post:With Monaghan Medical, Safe Nebulizer Therapy is PossibleMonaghan Medical Corporation Receives Zenith Award from American Association of Respiratory Care for Sixth Consecutive Year
PLATTSBURGH, NY (November 24, 2020)—Monaghan Medical Corporation (Monaghan Medical) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the sixth consecutive year. The award is presented annually by the AARC based on ballots cast by respiratory therapists, and receipt of the 2020 Zenith Award deemed even more meaningful as Monaghan’s products […]
Read the post:Monaghan Medical Corporation Receives Zenith Award from American Association of Respiratory Care for Sixth Consecutive YearAdherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory company
Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in the United States. […]
Read the post:Adherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory companyMonaghan Medical Corporation Opens New State-of-the-Art Manufacturing Facility in Plattsburgh, New York
New headquarters building doubles the operational size and is designed to place workers’ safety first during the COVID-19 pandemic PLATTSBURGH, NY (November 5, 2020) – Monaghan Medical Corporation (MMC) today announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building. The new facility will house Monaghan Medical’s warehouse, […]
Read the post:Monaghan Medical Corporation Opens New State-of-the-Art Manufacturing Facility in Plattsburgh, New YorkMonaghan Medical Corporation signs a Letter of Intent to enter into US sales agreement with Adherium, a global leader in digital respiratory health technologies
PLATTSBURGH, NY – 29 April 2020: Monaghan Medical Corporation today announced it has signed a letter of intent to enter into a sales agreement with Adherium Limited (ASX:ADR), a provider of digital health solutions for remote monitoring and data management. The partnership will combine Monaghan’s knowledge and expertise in improving patient outcomes through innovative respiratory […]
Read the post:Monaghan Medical Corporation signs a Letter of Intent to enter into US sales agreement with Adherium, a global leader in digital respiratory health technologiesMonaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment Option
Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika® oscillatory positive expiratory pressure (OPEP) device and the VersaPAP® positive airway pressure device—to create a low cost, safe and effective “tandem therapy”.
Read the post:Monaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment OptionMonaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care
Award recognizes MMC’s outstanding respiratory products and services, and commitment to excellence.
Read the post:Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory CareMonaghan Medical Corporation Introduces an Intermediate-Size Mask
Anatomically designed mask will assist millions of Americans suffering from chronic lung disease PLATTSBURGH, NY (June 5, 2019) – Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue their mission to ensure device quality for patients. Close to 50 million Americans suffer from asthma[i] or chronic obstructive pulmonary disease (COPD)[ii]—lung conditions that seriously […]
Read the post:Monaghan Medical Corporation Introduces an Intermediate-Size Mask